The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization

The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization

Abstract Background A single-centre cohort study was performed to identify the independent factors associated with the overall survival (OS) of hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization with drug-eluting beads (DEB-TACE). Methods A total of 216 HCC patients...

Full description

Bibliographic Details
Main Authors: María Pipa-Muñiz, Susana Sanmartino, Alicia Mesa, Carmen Álvarez-Navascués, Maria-Luisa González-Diéguez, Valle Cadahía, José-Eduardo Rodríguez, Florentino Vega, Manuel Rodríguez, Serafin-Marcos Costilla-García, María Varela
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Gastroenterology
Subjects:
Hepatocellular carcinoma
DEB-TACE
Ascites
Response
Survival
Online Access:http://link.springer.com/article/10.1186/s12876-020-01307-x

Internet

http://link.springer.com/article/10.1186/s12876-020-01307-x

Similar Items